Article info

Download PDFPDF
Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

Authors

  1. Correspondence to Dr Stephen J Tuft, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK; s.tuft{at}ucl.ac.uk
View Full Text

Citation

Petsoglou C, Balaggan KS, Dart JKG, et al
Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

Publication history

  • Received May 29, 2012
  • Revised September 17, 2012
  • Accepted September 21, 2012
  • First published October 20, 2012.
Online issue publication 
December 17, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.